Biomarker of Pulmonary Inflammatory Response in LUAD: miR-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.
Enyu YangYinuo HongCheng XuanJuan XuQianyun DingShuo ZhaoHaihan YeXiaowei FanZhenggang JiangSiquan ZhangXianfeng DingPublished in: Protein and peptide letters (2023)
Prognostic-related risk miR-584-5p can regulate the expression of RAB23 at both the mRNA and protein levels, thereby influencing the development of a PIR in LUAD. This will have significant implications for the clinical prognosis prediction and therapy decision-making of LUAD patients with PIR.
Keyphrases